title: Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma.
authors.forename: Brandi M
authors.initials: BM
authors.lastname: Kenner-Bell
authors.forename: Amy S
authors.initials: AS
authors.lastname: Paller
authors.forename: Mario E
authors.initials: ME
authors.lastname: Lacouture
mesh_terms: D000328:Adult; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005260:Female; D006229:Hand Dermatoses / Q000188:drug therapy*; D006801:Humans; D007645:Keratoderma, Palmoplantar / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors